Even though there has been no such study that investigated the effect of lacosamide on CGRP serum levels in migraine patients, our findings may be explained as lacosamide may reduce CGRP serum level by interaction with CRMP2 preventing its phosphorylation leading to the inhibition of CGRP [7]. The gene discussed is DPYSL2; the disease is migraine disorder.